Check out this week's Quadcast as we highlight the first randomized trial of SBRT vs. Surgery for prostate cancer, the impact of pembrolizumab on survival in triple negative breast cancer, and the improved survival in limited stage small cell lung cancer with the addition of Durvalumab.

Check out the website and subscribe to the newsletter!

www.quadshotnews.com

Founders & Lead Authors: Laura Dover & Caleb Dulaney

Podcast Host: Sam Marcrom